Related Searches
Definitions
Actemra
Nearby Words

Actemra

Actemra
See Tocilizumab
Wikipedia, the free encyclopedia © 2001-2006 Wikipedia contributors (Disclaimer)
This article is licensed under the GNU Free Documentation License.
Last updated on Saturday March 17, 2007 at 13:52:10 PDT (GMT -0700)
View this article at Wikipedia.org - Edit this article at Wikipedia.org - Donate to the Wikimedia Foundation

Related Articles
ACTEMRA Data Presented at ACR Annual Meeting on Rapid Response and Long-Term Efficacy in People with Rheumatoid Arthritis.
Nov 24, 2010; Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced updated data from a Phase III study (ROSE)...
Read more with a free trial on HighBeam.com »
Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients.
Jun 24, 2009; One-year data from the two-year Phase III LITHE (TociLIzumab Safety and THE Prevention of Structural Joint Damage) study...
Read more with a free trial on HighBeam.com »
Genentech: FDA Approves Expanded Indication for Actemra in Rheumatoid Arthritis
Oct 17, 2012; Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has expanded the approved indication...
Read more with a free trial on HighBeam.com »
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection.
May 29, 2012; Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the SUMMACTA study met its primary endpoint,...
Read more with a free trial on HighBeam.com »
Roche's Actemra inhibits RA joint damage to boost QoL, according to Ph III LITHE data.
May 19, 2008; Late-stage trial data show that Roche's Actemra (tocilizumab) can significantly inhibit structural damage to joints in...
Read more with a free trial on HighBeam.com »
HighBeam Research, Inc. © Copyright 2009.

Search another word or see Actemraon Dictionary | Thesaurus |Spanish
  • Please Login or Sign Up to use the Recent Searches feature
FAVORITES
RECENT